Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Farmers Insurance
Covington
Federal Trade Commission
Baxter
Chinese Patent Office
Cipla
Johnson and Johnson
Boehringer Ingelheim

Generated: April 24, 2018

DrugPatentWatch Database Preview

BEXTRA Drug Profile

« Back to Dashboard

When do Bextra patents expire, and what generic alternatives are available?

Bextra is a drug marketed by Gd Searle and is included in one NDA.

The generic ingredient in BEXTRA is valdecoxib. Additional details are available on the valdecoxib profile page.
Drug patent expirations by year for BEXTRA
Synonyms for BEXTRA
181695-72-7
2919279Q3W
2aw1
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide
4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
4-(Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
4-[5-methyl-3-phenylisoxazol-4-yl]benzensulfonamide
4CH-003246
695V727
A812629
AB00639996_10
AB00639996-08
AB0125618
ABP000351
AC-120
AC1L3P42
ACM1189428236
AJ-08285
AK122221
AKOS000280920
AN-16123
API0004561
AX8016203
BC209355
BDBM13063
Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-
Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)- (9CI)
Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-(9CI)
Bextra(Valdecoxib)
BRD-K12994359-001-02-8
BSPBio_002721
C-19398
C16H14N2O3S
C21552
CAS-181695-72-7
CC-35561
CCG-39589
CHEBI:63634
CHEMBL865
cid_119607
COX
CPD000466327
CS-1674
CTK8E7482
D02709
D0L6DA
DB00580
DR001345
DSSTox_CID_24226
DSSTox_GSID_44226
DSSTox_RID_80128
DTXSID6044226
EX-A241
FT-0631199
GTPL2894
HE319792
HMS1922J21
HMS2051P07
HMS2232P23
HMS3372D12
HMS3393P07
HMS3652I04
HSDB 7302
HY-15762
I14-44902
InChI=1/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20
J-011613
J-513600
KB-62216
KBio2_002227
KBio2_004795
KBio2_007363
KBio3_001941
KBioGR_001617
KBioSS_002227
KS-00000XKX
Kudeq
LNPDTQAFDNKSHK-UHFFFAOYSA-N
LS-173713
MFCD00950568
MLS000759433
MLS001165699
MLS001195631
MLS001424105
MolPort-000-883-874
MRF-0000216
NC00184
NCGC00095129-01
NCGC00095129-02
NCGC00095129-03
NCGC00095129-06
ND-0214
NSC-759846
NSC759846
p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
Pfizer brand of valdecoxib
Pharmakon1600-01504302
RL02316
RT-016210
s4049
SAM001246603
SC 65872
SC-19235
SC-65872
SCHEMBL3356
SMR000466327
SPBio_000435
Spectrum_001747
SPECTRUM1504302
Spectrum2_000508
Spectrum3_001001
Spectrum4_001129
Spectrum5_001476
ST24042991
Tox21_111438
Tox21_111438_1
UNII-2919279Q3W
UNM-0000305814
Valdecoxib
Valdecoxib (USAN/INN)
Valdecoxib [USAN:INN:BAN]
Valdecoxib [USAN]
Valdecoxib, >=98% (HPLC)
Valdecoxib, analytical reference material
Valdecoxib/
valdecoxibum
Valdyn
Valecoxib
Vatdecoxib
VLX
YM-974
ZB000648
ZINC6694

US Patents and Regulatory Information for BEXTRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for BEXTRA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Federal Trade Commission
Colorcon
Accenture
Baxter
Covington
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.